You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2024-06-20T00:00:00", "title": "AO 24-04", "url": "https://oig.hhs.gov/compliance/advisory-opinions/24-04/", "attachments": [{"title": "Advisory Opinion 24-04", "url": "https://oig.hhs.gov/documents/advisory-opinions/9915/AO-24-04.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-24-04", "subagency": "Office of the Inspector General", "summary": "Favorable opinion regarding: (i) a limited-time program to refund, waive, or delay requiring receipt of payment for a drug in the event of an insurance reimbursement denial or delay; and (ii) certain discounts to the cost of the drug."}